Andrew Weaver

2.5k total citations
35 papers, 953 citations indexed

About

Andrew Weaver is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Andrew Weaver has authored 35 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Hematology and 6 papers in Surgery. Recurrent topics in Andrew Weaver's work include Hematopoietic Stem Cell Transplantation (7 papers), Colorectal Cancer Surgical Treatments (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Andrew Weaver is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Colorectal Cancer Surgical Treatments (5 papers) and Antibiotic Resistance in Bacteria (4 papers). Andrew Weaver collaborates with scholars based in United Kingdom, United States and Canada. Andrew Weaver's co-authors include NG Testa, Sarah Pearson, Min Wu, Lionel Tarassenko, Annie Young, V. Wee Yong, Robert K. Nuttall, Mark Larsen, Steven D. Shapiro and Dylan R. Edwards and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew Weaver

33 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Weaver United Kingdom 17 381 175 173 130 116 35 953
Eun‐Kee Song South Korea 22 623 1.6× 245 1.4× 86 0.5× 80 0.6× 144 1.2× 80 1.4k
Anne Rigg United Kingdom 13 379 1.0× 209 1.2× 60 0.3× 44 0.3× 76 0.7× 37 971
Roberto Rivera‐Luna Mexico 16 176 0.5× 129 0.7× 67 0.4× 141 1.1× 46 0.4× 67 808
Haesook Kim United States 17 488 1.3× 339 1.9× 183 1.1× 227 1.7× 660 5.7× 55 1.7k
Maria Olsen Netherlands 12 318 0.8× 132 0.8× 135 0.8× 29 0.2× 89 0.8× 20 923
Hui‐Chun Hsu Taiwan 17 216 0.6× 146 0.8× 115 0.7× 104 0.8× 80 0.7× 50 815
Samart Pakakasama Thailand 25 334 0.9× 434 2.5× 123 0.7× 472 3.6× 168 1.4× 130 1.6k
Charlotte Bradbury United Kingdom 15 194 0.5× 451 2.6× 136 0.8× 308 2.4× 47 0.4× 36 1.1k
Maria Moschovi Greece 23 427 1.1× 633 3.6× 198 1.1× 297 2.3× 117 1.0× 104 1.9k
Rafael Peris‐Bonet Spain 20 306 0.8× 247 1.4× 124 0.7× 45 0.3× 26 0.2× 31 1.6k

Countries citing papers authored by Andrew Weaver

Since Specialization
Citations

This map shows the geographic impact of Andrew Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Weaver more than expected).

Fields of papers citing papers by Andrew Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Weaver. The network helps show where Andrew Weaver may publish in the future.

Co-authorship network of co-authors of Andrew Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Weaver. A scholar is included among the top collaborators of Andrew Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Weaver. Andrew Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fyke, Jeremy & Andrew Weaver. (2023). Reducing personal climate risk to reduce personal climate anxiety. Nature Climate Change. 13(3). 209–210. 11 indexed citations
2.
Mulcahy, Mary F., Riad Salem, Armeen Mahvash, et al.. (2021). LBA21 Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study). Annals of Oncology. 32. S1295–S1295. 5 indexed citations
3.
Mukherjee, Somnath, et al.. (2019). Intensity-Modulated Radiotherapy With a Simultaneous Integrated Boost in Rectal Cancer. Clinical Oncology. 32(1). 35–42. 20 indexed citations
4.
Weaver, Andrew, et al.. (2019). Mechanistic research holds promise for bacterial vaccines and phage therapies for Pseudomonas aeruginosa. SHILAP Revista de lepidopterología. 1 indexed citations
5.
6.
Weaver, Andrew, Qinqin Pu, Ting Huang, et al.. (2019). <p>Mechanistic research holds promise for bacterial vaccines and phage therapies for <em>Pseudomonas aeruginosa</em></p>. Drug Design Development and Therapy. Volume 13. 909–924. 35 indexed citations
7.
Kerr, Rachel, Sharon Love, Eva Segelov, et al.. (2016). Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial. The Lancet Oncology. 17(11). 1543–1557. 95 indexed citations
8.
Weaver, Andrew, Sharon Love, Mark Larsen, et al.. (2014). A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring — supporting patients in their homes. Supportive Care in Cancer. 22(10). 2677–2685. 23 indexed citations
9.
Huang, Huang, Andrew Weaver, Erxi Wu, et al.. (2013). Lipid-Based Signaling Modulates DNA Repair Response and Survival against Klebsiella pneumoniae Infection in Host Cells and in Mice. American Journal of Respiratory Cell and Molecular Biology. 49(5). 798–807. 18 indexed citations
10.
Yuan, Kefei, Canhua Huang, John Fox, et al.. (2011). Elevated Inflammatory Response in Caveolin-1-deficient Mice with Pseudomonas aeruginosa Infection Is Mediated by STAT3 Protein and Nuclear Factor κB (NF-κB). Journal of Biological Chemistry. 286(24). 21814–21825. 80 indexed citations
11.
Korevaar, Tim I.M., Federico Ragazzoni, Andrew Weaver, Niki Karavitaki, & Ashley Grossman. (2011). IGF2-induced hypoglycemia unresponsive to everolimus. QJM. 107(4). 297–300. 9 indexed citations
12.
Farmer, Andrew, et al.. (2011). Mobile health for drug dose optimisation. PubMed. 9. 1540–1543. 5 indexed citations
13.
Wu, Min, Huang Huang, Weidong Zhang, et al.. (2010). Host DNA Repair Proteins in Response to Pseudomonas aeruginosa in Lung Epithelial Cells and in Mice. Infection and Immunity. 79(1). 75–87. 42 indexed citations
14.
Young, A. J., Lionel Tarassenko, Andrew Weaver, et al.. (2008). Mobile phone technology for managing chemotherapy associated side-effects. Oncology nursing forum. 35. 559–559. 1 indexed citations
15.
Larsen, Mark, Annie Young, Sarah Pearson, et al.. (2008). Chemotherapy side-effect management using mobile phones. PubMed. 2008. 5152–5155. 33 indexed citations
16.
Weaver, Andrew, Annie Young, Nick Townsend, et al.. (2007). Application of mobile phone technology for managing chemotherapy-associated side-effects. Annals of Oncology. 18(11). 1887–1892. 121 indexed citations
17.
Weaver, Andrew & NG Testa. (1998). Stem cell factor leads to reduced blood processing during apheresis or the use of whole blood aliquots to support dose-intensive chemotherapy. Bone Marrow Transplantation. 22(1). 33–38. 19 indexed citations
18.
Testa, Nydia G., et al.. (1996). The study of haemopoietic stem cells in patients: Concepts, approaches and cautionary tales. Annals of Oncology. 7. 5–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026